Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
September 14, 2022
The article from CBDL, describes how FDNA’s new algorithm has made a breakthrough in diagnosing a patient with an ultra-rare syndrome. By employing this advanced tool, Face2Gene, FDNA uses sophisticated AI algorithms to analyze facial features and detect genetic anomalies. This innovative approach identifies ultra-rare syndromes by comparing patient photos to an extensive database of known genetic conditions. The algorithm’s accuracy and speed in providing expedited diagnostic insights mark a significant achievement. FDNA’s work highlights the transformative impact of AI in healthcare, particularly in diagnosing ultra-rare syndromes, leading to more accurate diagnoses and personalized treatment plans for genetic disorder patients.
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…